OLFM4 and chronic myelogenous leukemia, BCR-ABL1 positive: Consistent with prior observations in iCD34+ cells, CML cells in clonogenic cultures displayed a significant upregulation of OLFM4 expression when pretreated with imatinib (Fig. 6a and Supplementary Fig. S5).